A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 352 participants.
Also called NCT07352969
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 352 participants
- Registry
-
NCT07352969
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07352969. Randomized; quadruple masking; primary purpose treatment. Start 2026-02-05 (actual); primary completion 2029-03-27 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients
- Condition
- Hypertension
- Intervention (Drug)
- IBI3016
- Intervention (Other)
- Placebo
- Lead sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
Record details
- Record id
cardio:ct-nct07352969- Content hash
109e83580dfb373d7309ccadbe58c1ff1aa7391396fb704d76a0f90669fa52ca